DocMorris announces results of Tender Offer – Biotech Investments

Cybin Announces Closing of Offering of Units Led by One of the Company’s Largest Institutional Shareholders | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment

November 14, 2023

Pharma’s data and analytics market forecast to reach to $2.1bn by 2028 – Pharmaceutical Technology

The global data and analytics market will see a CAGR of 9.5% between 2022 and 2028. Credit: Smallroombigdream / Shutterstock. Data content management will drive

December 18, 2024

Inflammatory activity in rheumatoid arthritis impacts cognitive function

The inflammatory activity in the body caused by rheumatoid arthritis is linked to specific cognitive impairments, finds a small comparative study, published in the open

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.